HOME › DRUGS › DENOSUMAB-QBDE
ACTIVE SUBSTANCE / INN

DENOSUMAB-QBDE

Brand name(s): ENOBY, XTRENBO
FDA LISTED
PRESCRIPTION
BLA761439
ACTIVE SUBSTANCE
Denosumab-Qbde
REGULATORS
FDA
SPONSORS / MAH
HIKMA PHARMACEUTICALS USA INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ENOBYBLA761439HIKMA PHARMACEUTICALS USA INCPrescription
XTRENBOBLA761439HIKMA PHARMACEUTICALS USA INCPrescription

FULL INTELLIGENCE ON DENOSUMAB-QBDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →